Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Buy dildos and adult toys.
Popular Articles

Washington Post Examines Lobbying Efforts Of Health Information Technology Industry
The Washington Post on Saturday examined the role of the Healthcare Information and Management Systems Society in lobbying for the national adoption of health information technology as part of health reform efforts. According to the Post, HIMSS has collaborated with various allies, including technology vendors and research groups, "in a sophisticated, decade-long campaign to shape public opinion and win over Washington"s political machinery."HIMSS in the early part of this decade forged a "strategic alliance" with the Center for Information Technology Leadership, a not-for-profit health IT research group in Massachusetts, to develop and distribute data reports on the cost efficiency and benefits of health IT, the Post reports. CITL also had sponsorship ties with several health and technology companies, including Google, Microsoft, Kaiser Permanente and Siemens Medical Solutions. In 2004, CITL issued a report that concluded in part that a national health IT system could reduce spending by as much as $77.8 billion by limiting drug prescribing errors and notifying providers of more cost-effective drug alternatives.According to the Post, the findings of the report were used by the Obama administration in developing the $787 billion federal economic stimulus package, which included billions in new spending for the creation and adoption of health IT systems. Although a Congressional Budget Office report found that the assumptions of CITL report were "overly optimistic" -- a follow-up CBO analysis projected that electronic health records would reduce health care spending by $17 billion over 10 years -- the health IT measures in the stimulus package "represented a triumph" for HIMSS, "whose members now stand to gain billions in taxpayer dollars," the Post reports. The Post notes that HIMSS" "sudden success shows how the economic crisis created a remarkable opening for a political and financial windfall: the enactment of a sweeping new policy with no bureaucratic delays and virtually no public debate about an initiative aimed at transforming a sector that accounts for more than a sixth of the American economy" (O"Harrow, Washington Post, 5/16).Please note: The Kaiser Family Foundation is not associated with Kaiser Permanente or Kaiser Industries.
buy viagra
Pseudoephedrine Decision Demonstrates Confidence In Community Pharmacy
The NPA is pleased by today"s decision from the MHRA to keep pseudoephedrine a P medicine and have no doubt that community pharmacies will continue to ensure pseudoephedrine is sold in line with MHRA guidance.
News of the day
Altair Therapeutics Reports Successful Completion Of Phase I Study Of Inhaled AIR645
Altair Therapeutics, Inc., a privately-held, biopharmaceutical company developing novel therapeutics for respiratory diseases, reported results from its phase I study evaluating the safety, tolerability and pharmacokinetics of its lead product, once-weekly inhaled AIR645, in healthy volunteers. AIR645 is a non-steroidal dual inhibitor of cellular responses to interleukin (IL)-4 and IL-13, cytokines that play a critical role in development and progression of asthma, rhinitis and other allergic disorders. Results presented today at the 2009 International Conference of the American Thoracic Society (ATS) within the Mini-Symposium "New Treatment Approaches for Asthma and Allergy" showed that inhaled AIR645 was safe, well tolerated and had dose-dependent exposure in the airways. These results demonstrate the potential of AIR645 as a convenient once-weekly treatment for asthma and other respiratory disorders. Later this year, Altair plans to initiate a phase II efficacy study in patients with asthma.
Oncology

Digital Medicine: Health Care In The Internet Era

With more than $19 billion in new spending planned for health information technology, the Obama administration is taking serious steps toward modernizing the U.S. health care system. Implementing health IT can reduce both costs and errors, but it requires extensive information infrastructure upgrades. Few hospitals, clinics or private practices have the funds to pay for new technology. The new Brookings Institution Press book Digital Medicine: Health Care in the Internet Era investigates the factors affecting digital technology"s ability to remake health care. Darrell M. West, vice president and director of Governance Studies at Brookings, and Edward Alan Miller, assistant professor at Brown University, explore the political, social and ethical challenges presented by online health care, as well as the impact that racial, ethnic and other disparities are having on the e-health revolution. They examine the accessibility of health-related websites for different populations and ask how we can close access gaps and ensure the reliability and trustworthiness of the information presented online. Governments, hospitals, doctors and pharmaceutical manufacturers have placed a tremendous amount of medical information, data and services online in recent years. However, few people use the Internet to search for health information, purchase prescription drugs online or e-mail health care providers. West and Miller use original survey research and website analysis to study the content, sponsorship status and public usage of these health care-related websites. They examine the relationship between e-health utilization and attitudes about health care in the United States and explore the use of health information technology in other countries. The authors find that information technology will not dramatically improve health care in America until policy-makers and health care officials understand and address key obstacles such as technology costs, electronic communications problems, ethical issues, privacy concerns and disparities between social groups. The Authors Darrell M. West is vice president and director of Governance Studies at Brookings. Previously, he was the John Hazen White Professor of Political Science and Public Policy and director of the Taubman Center for Public Policy at Brown University. He is the author of 16 books, including Digital Government: Technology and Public Sector Performance (Princeton, 2005), Biotechnology Policy across National Boundaries (Palgrave MacMillan, 2007) and Air Wars: Television Advertising in Election Campaigns, 1952-2008 (CQ Press, 2009). Edward Alan Miller is currently an assistant professor of public policy, political science, and community health at Brown University and faculty associate at Brown"s Center for Gerontology and Health Care Research. Next fall he will become an associate professor of public policy and gerontology at the University of Massachusetts Boston. A former Fulbright scholar and social policy analyst at the Congressional Research Service trained in political science and health services research at Yale University and the University of Michigan, he is the author of more than 80 journal articles, book chapters and reports on aging and long-term care, telemedicine and e-health, and intergovernmental relations. The Brookings Institution


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009